Skip to main content
. 2021 Dec 10;13(24):6225. doi: 10.3390/cancers13246225

Figure 3.

Figure 3

(A) Recovery rate of the OC cell lines after enrichment with Parsortix™ and subsequent detection by immunostaining. (B) Comparison of the cell diameters of the two OC cell lines (n = 10).